Skip to main content

Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells

Tumor Biology volume 37, pages 7573–7582 (2016)Cite this article

Abstract

Stem cell therapies are important treatment methodologies used in many areas of experimental or clinical medicine. In recent studies of cancer models, Mesenchymal stem cells (MSCs) suppressed the growth of cancer cells. However, also in some studies, stem cell treatments have been shown to induce cancer formation, increase tumor volume, induce the formation of new vessels, and lead to cancer invasion. The presence of MSC-secreted cytokines and their effects on cancer cells limits the reliability of MSC-based treatments. Resveratrol (trans-3,5,4′-trihydroxystilbene), an antioxidant found in red wine, has been shown to have therapeutic effects against several cancers. The aim of this study was to co-culture MSCs with A549 cancer cells to suppress the release of cancer-promoting cytokines from MSCs and to increase the applicability and reliability of stem cell therapies with resveratrol. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and neutral red cell viability assays were used to find safety dose of resveratrol. The MSCs secreted the cytokines IL-6 and VEGF, and the effect of resveratrol on these cytokines was analyzed by ELISA and western blot analysis of conditioned medium. One μM of resveratrol was found to be the safety dose for the A549 cancer cells and MSCs. We observed the highest release of IL-6 and VEGF from the co-cultured A549 cells and MSCs, and resveratrol was found to significantly decrease the release of these cytokines. Our study suggests that resveratrol exerts a positive effect on the release of cytokines. The safety dose of resveratrol can be administered together with stem cells during stem cell treatment.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Yao W, Hu Q, Ma Y, Xiong W, Wu T, Cao J et al. Human adipose-derived mesenchymal stem cells repair cisplatin-induced acute kidney injury through antiapoptotic pathways. Exp Ther Med. 2015.

  2. Hou L, Wang X, Zhou Y, Ma H, Wang Z, He J, et al. Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells. Tumor Biol. 2014;35(2):1239–50.

    CAS  Article  Google Scholar 

  3. Bang OY. Autologous mesenchymal stem cell therapy in patients with stroke. Cell Therapy for Brain Injury. Springer; 2015. p. 21–35.

  4. Wei X, Yang X. Han Z-p, Qu F-f, Shao L, Shi Y-f. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747–54.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012;5(1):19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Torsvik A, Bjerkvig R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev. 2013;39(2):180–8.

    CAS  Article  PubMed  Google Scholar 

  7. Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res. 2011;71(2):614–24.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. Saglam O, Unal ZS, Subasi C, Ulukaya E, Karaoz E. IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis. Tumour Biol J Int Soc Oncol Dev Biol Med. 2015;36(7):5667–77.

    CAS  Article  Google Scholar 

  9. Smith PC, Hobisch A, Lin D-L, Culig Z, Keller ET. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev. 2001;12(1):33–40.

    CAS  Article  PubMed  Google Scholar 

  10. George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, et al. Vegf-a, vegf-c, and vegf-d in colorectal cancer progression. Neoplasia. 2001;3(5):420–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Galie M, Konstantinidou G, Peroni D, Scambi I, Marchini C, Lisi V, et al. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene. 2008;27(18):2542–51.

    CAS  Article  PubMed  Google Scholar 

  12. Tao K, Bai X, Jia W, Liu Y, Zhu X, Han J, et al. Effects of resveratrol on the treatment of inflammatory response induced by severe burn. Inflammation. 2015;38(3):1273–80.

    CAS  Article  PubMed  Google Scholar 

  13. Tung BT, Rodríguez-Bies E, Talero E, Gamero-Estévez E, Motilva V, Navas P, et al. Anti-inflammatory effect of resveratrol in old mice liver. Exp Gerontol. 2015;64:1–7.

    CAS  Article  PubMed  Google Scholar 

  14. Yu XD, Yang JL, Zhang WL, Liu DX. Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol J Int Soc Oncol Dev Biol Med. 2015.

  15. Yan H-W, Hu W-X, Zhang J-Y, Wang Y, Xia K, Peng M-Y, et al. Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy. Tumor Biol. 2014;35(6):5381–8.

    CAS  Article  Google Scholar 

  16. Peltz L, Gomez J, Marquez M, Alencastro F, Atashpanjeh N, Quang T, et al. Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PLoS One. 2012;7(5):e37162.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. Zakaria N, Yusoff NM, Zakaria Z, Lim MN, Baharuddin PJN, Fakiruddin KS, et al. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells. BMC Cancer. 2015;15(1):84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Borenfreund E, Puerner JA. A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90). J Tissue Cult Methods. 1985;9(1):7–9.

    Article  Google Scholar 

  19. Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22.

    CAS  Article  PubMed  Google Scholar 

  20. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17(1):11–22.

    CAS  Article  PubMed  Google Scholar 

  21. Galderisi U, Giordano A, Paggi MG. The bad and the good of mesenchymal stem cells in cancer: boosters of tumor growth and vehicles for targeted delivery of anticancer agents. World J Stem Cells. 2010;2(1):5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211(1):27–35.

    CAS  Article  PubMed  Google Scholar 

  23. Scherzad A, Steber M, Gehrke T, Rak K, Froelich K, Schendzielorz P, et al. Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2. Int J Oncol. 2015;47(1):391–7.

    PubMed  Google Scholar 

  24. Agrawal M, Kumar V, Kashyap MP, Khanna VK, Randhawa GS, Pant AB. Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. Eur J Pharmacol. 2011;666(1):5–11.

    CAS  Article  PubMed  Google Scholar 

  25. Kumar V, Tripathi VK, Singh AK, Lohani M, Kuddus M. Trans-resveratrol restores the damages induced by organophosphate pesticide-monocrotophos in neuronal cells. Toxicol Int. 2013;20(1):48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gu S, Chen C, Jiang X, Zhang Z. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Biol Trace Elem Res. 2015;163(1–2):112–23.

    CAS  Article  PubMed  Google Scholar 

  27. Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E, et al. Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Anal Cell Pathol. 2010;33(2):61–79.

    CAS  Article  Google Scholar 

  28. Hsu H-S, Lin J-H, Hsu T-W, Su K, Wang C-W, Yang K-Y, et al. Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway. Lung Cancer. 2012;75(2):167–77.

    Article  PubMed  Google Scholar 

  29. Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK et al., editors. Broad targeting of angiogenesis for cancer prevention and therapy. Seminars in cancer biology; 2015: Elsevier.

  30. Scherzed A, Hackenberg S, Radeloff A, Froelich K, Rak K, Hagen R, et al. Human mesenchymal stem cells promote cancer motility and cytokine secretion in vitro. Cells Tissues Organs. 2013;198(5):327–37.

    CAS  Article  PubMed  Google Scholar 

  31. Chowdhury R, Webber JP, Gurney M, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget. 2015;6(2):715.

    Article  PubMed  Google Scholar 

  32. Chen D, Liu S, Ma H, Liang X, Ma H, Yan X, et al. Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int. 2015;15(1):42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was financed by a grant from the Eskisehir Osmangazi University. The authors are grateful to Eskisehir Osmangazi University, Commission of Scientific Research Projects for financial support to Project 201411038. Authors also thank deeply the Anadolu University Biology Department and Dr. R. Beklem Bostancioglu for their kind help.

Author information

Affiliations

  1. Medicine School, Histology and Embryology Department, Eskisehir Osmangazi University, Meselik campus, 26480, Eskisehir, Turkey

    Erhan Sahin, Cengiz Baycu, Dilek Burukoglu Donmez & Ezgi Bektur

  2. Faculty of Science, Department of Biology, Anadolu University, Eskisehir, Turkey

    Ayse Tansu Koparal

Authors
  1. Erhan Sahin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cengiz Baycu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayse Tansu Koparal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dilek Burukoglu Donmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ezgi Bektur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erhan Sahin.

Ethics declarations

Conflicts of interest

The authors declare that there are no conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sahin, E., Baycu, C., Koparal, A.T. et al. Resveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cells. Tumor Biol. 37, 7573–7582 (2016). https://doi.org/10.1007/s13277-015-4643-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-4643-0

Keywords

  • Mesenchymal stem cells
  • Cancer cells
  • A549
  • IL-6
  • VEGF and resveratrol